Plasma lipoproteome in Alzheimer’s disease: a proof-of-concept study

被引：0
|
作者：
Danni Li
Fangying Huang
Yingchun Zhao
Peter W. Villata
Timothy J. Griffin
Lin Zhang
Ling Li
Fang Yu
机构：
[1] University of Minnesota,Department of Laboratory Medicine and Pathology
[2] University of Minnesota,Masonic Cancer Center
[3] University of Minnesota,Department of Biochemistry, Molecular Biology, and Biophysics
[4] University of Minnesota,Department of Biostatistics
[5] University of Minnesota,Department of Experimental and Clinical Pharmacology
[6] University of Minnesota,School of Nursing
来源：
Clinical Proteomics | 2018年 / 15卷
关键词：
Alzheimer’s disease; Plasma lipoproteins; Targeted proteomics; Complement C3; Very low-density lipoprotein (VLDL); Intermediate density lipoprotein (IDL); Low density lipoprotein (LDL); High-density lipoprotein (HDL); Biomarker; Diagnosis; Selected reaction monitoring (SRM);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Double-blind, placebo-controlled, proof-of-concept trial of bexarotene in moderate Alzheimer’s disease
    Jeffrey L. Cummings
    Kate Zhong
    Jefferson W. Kinney
    Chelcie Heaney
    Joanne Moll-Tudla
    Abhinay Joshi
    Michael Pontecorvo
    Michael Devous
    Anne Tang
    James Bena
    Alzheimer's Research & Therapy, 8
  • [22] The Proof-of-Concept of MBA121, a Tacrine-Ferulic Acid Hybrid, for Alzheimer's Disease Therapy
    Rodriguez-Ruiz, Emelina R.
    Herrero-Labrador, Raquel
    Fernandez-Fernandez, Ana P.
    Serrano-Masa, Julia
    Martinez-Montero, Jose A.
    Gonzalez-Nieto, Daniel
    Hana-Vaish, Mayuri
    Benchekroun, Mohamed
    Ismaili, Lhassane
    Marco-Contelles, Jose
    Martinez-Murillo, Ricardo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
  • [23] Just a Small, Proof-of-Concept Study
    Novack, Gary D.
    OCULAR SURFACE, 2009, 7 (02): : 111 - 112
  • [24] Phonetic compliance: a proof-of-concept study
    Delvaux, Veronique
    Huet, Kathy
    Piccaluga, Myriam
    Harmegnies, Bernard
    FRONTIERS IN PSYCHOLOGY, 2014, 5
  • [25] Application of Clinical Trial Simulation to Compare Proof-of-Concept Study Designs for Drugs with a Slow Onset of Effect; An Example in Alzheimer's Disease
    Peter Lockwood
    Wayne Ewy
    David Hermann
    Nick Holford
    Pharmaceutical Research, 2006, 23
  • [26] A PROOF-OF-CONCEPT STUDY OF A MAGNETORHEOLOGICAL MICROPUMP
    Cesmeci, Sevki
    Hassan, Rubayet
    Thompson, Mark
    PROCEEDINGS OF ASME 2022 INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION, IMECE2022, VOL 2B, 2022,
  • [27] Inhaled insulin: A proof-of-concept study
    Cefalu, WT
    ANNALS OF INTERNAL MEDICINE, 2001, 134 (09) : 795 - 795
  • [28] Cannabidiol Treatment Improves Glucose Metabolism and Memory in Streptozotocin-Induced Alzheimer's Disease Rat Model: A Proof-of-Concept Study
    de Paula Faria, Daniele
    Estessi de Souza, Larissa
    Duran, Fabio Luis de Souza
    Buchpiguel, Carlos Alberto
    Britto, Luiz Roberto
    Crippa, Jose Alexandre de Souza
    Busatto Filho, Geraldo
    Real, Caroline Cristiano
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [29] Application of clinical trial simulation to compare proof-of-concept study designs for drugs with a slow onset of effect; an example in Alzheimer's disease
    Lockwood, Peter
    Ewy, Wayne
    Hermann, David
    Holford, Nick
    PHARMACEUTICAL RESEARCH, 2006, 23 (09) : 2050 - 2059
  • [30] Extensive frontal focused ultrasound mediated blood-brain barrier opening for the treatment of Alzheimer's disease: a proof-of-concept study
    Park, So Hee
    Baik, Kyoungwon
    Jeon, Seun
    Chang, Won Seok
    Ye, Byoung Seok
    Chang, Jin Woo
    TRANSLATIONAL NEURODEGENERATION, 2021, 10 (01)
12345